why choose us

First received: December 26, 2024

Clinical Trial: Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Thrombocytopaenia

Study Type: OBSERVATIONAL


Official Title: Comparative Study Between Incidence of Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Patients With Impaired Renal Function

Brief Summary: Linezolid exhibits a broad spectrum of activity against Gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant enterococci.The major adverse effect associated with linezolid treatment is reversible myelosuppression, mostly thrombocytopenia.Recent studies have reported that the incidence of linezolid-induced thrombocytopenia was higher among patients with renal failure than in patients with normal renal function, although the underlying mechanisms explaining…

Read more